About NEXT Life Sciences
NEXT Life Sciences is a company based in San Luis Obispo (United States) founded in 2021 by L R Fox. NEXT Life Sciences has raised $4.05 million across 2 funding rounds from investors including StartUp Health, The Family and Transform VC. NEXT Life Sciences offers products and services including Reproductive Healthcare Solutions and Information and Trials. NEXT Life Sciences operates in a competitive market with competitors including Esprit Pharma, Lipella, Regenfro Co, Kissei Pharmaceutical and TheraVida, among others.
- Headquarter San Luis Obispo, United States
- Founders L R Fox
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Next Life Sciences, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.05 M (USD)
in 2 rounds
-
Latest Funding Round
$2.5 M (USD), Seed
Jan 16, 2024
-
Investors
StartUp Health
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NEXT Life Sciences
NEXT Life Sciences offers a comprehensive portfolio of products and services, including Reproductive Healthcare Solutions and Information and Trials.
Offers support and resources for couples in family planning.
Provides details on reproductive health trials and inquiries.
Funding Insights of NEXT Life Sciences
NEXT Life Sciences has successfully raised a total of $4.05M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2.5 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NEXT Life Sciences
NEXT Life Sciences has secured backing from 9 investors, including venture fund and angel investors. Prominent investors backing the company include StartUp Health, The Family and Transform VC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
An accelerator focused on empowering pre-seed startup founders.
|
Locked | Locked | Locked | |
|
Early-stage technology companies are funded by Transform VC.
|
Locked | Locked | Locked | |
|
Online information platform of health and wellness
|
Locked | Locked | Locked |
Investor details for NEXT Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NEXT Life Sciences
Investment portfolio details for NEXT Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NEXT Life Sciences
Detailed financials for NEXT Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Next Life Sciences Comparisons
Peer comparison for NEXT Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NEXT Life Sciences
NEXT Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Esprit Pharma, Lipella, Regenfro Co, Kissei Pharmaceutical and TheraVida, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Develop drugs for genitourinary (GU) disorders
|
|
| Locked | Locked | Locked |
Lipid-based therapies for common bladder syndromes are developed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics to treat renal diseases
|
|
| Locked | Locked | Locked |
Therapies for renal diseases and urology-related anemia are developed.
|
|
| Locked | Locked | Locked |
Clinical stage biopharma company developing drugs for urology and central nervous system disorders
|
Detailed competitors of NEXT Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Next Life Sciences
Complete news archive for NEXT Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NEXT Life Sciences
NEXT Life Sciences was founded in 2021 and raised its 1st funding round 2 years after it was founded.
NEXT Life Sciences is headquartered in San Luis Obispo, United States. It is registered at San Luis Obispo, California, United States.
L R Fox is the current CEO of NEXT Life Sciences. They have also founded this company.
NEXT Life Sciences is a funded company, having raised a total of $4.05M across 2 funding rounds to date.
NEXT Life Sciences was founded in 2021 in San Luis Obispo, United States, focusing on the biotechnology sector for reproductive health. Non-hormonal, reversible male contraception methods are provided through the Plan A procedure, which utilizes Vasalgel to block sperm transport in the vas deferens without permanent severance, as seen in traditional vasectomies. Operations center on advancing these minimally invasive options for family planning.
NEXT Life Sciences's top competitors include Lipella, Kissei Pharmaceutical and Regenfro Co.
NEXT Life Sciences offers Reproductive Healthcare Solutions and Information and Trials.
NEXT Life Sciences has 9 investors. Key investors include StartUp Health, The Family, Transform VC, Brock Pierce, and Pay It Forward Venture Capital.